Suppr超能文献

长链非编码 RNA TP73-AS1 通过竞争性吸附 miR-449a/EZH2 促进非小细胞肺癌进展。

Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2.

机构信息

Department of Respiratory Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

Department of Respiratory Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

出版信息

Biomed Pharmacother. 2018 Aug;104:705-711. doi: 10.1016/j.biopha.2018.05.089. Epub 2018 May 25.

Abstract

Long noncoding RNAs (lncRNAs) are a type of noncoding RNA transcript that are characterized by lack of protein-coding capacity. The vital role of lncRNAs in non-small cell lung cancer (NSCLC) is attracting increasingly more attention. In the present study, we investigate the role of lncRNA antisense RNA of the TP73 gene (TP73-AS1) in NSCLC carcinogenesis. The results demonstrate that TP73-AS1 is markedly upregulated in NSCLC tissues, and functional experiments revealed that TP73-AS1 is significantly increased in NSCLC tissue and cell lines, indicating a possible oncogenic role. In loss-of-function assays, the knockdown of TP73-AS1 inhibited NSCLC cell proliferation, tumor growth and cycle progression in vivo and in vitro. Bioinformatic tools predicted that miR-449a both targeted the 3'-UTR of TP73-AS1 and EZH2, which was confirmed using luciferase reporter assay and AGO2-dependent RNA immunoprecipitate (RIP). TP73-AS1 and miR-449a were in the same RNA-induced silencing complex (RISC). In summary, the results indicate an explicit oncogenic role of TP73-AS1 in the NSCLC tumorigenesis, suggesting a TP73-AS1-miR-449a-EZH2 axis and providing new insight for NSCLC tumorigenesis.

摘要

长链非编码 RNA(lncRNA)是一种非编码 RNA 转录本,其特征是缺乏蛋白质编码能力。lncRNA 在非小细胞肺癌(NSCLC)中的重要作用越来越受到关注。在本研究中,我们研究了 TP73 基因反义 RNA(TP73-AS1)在 NSCLC 发生中的作用。结果表明,TP73-AS1 在 NSCLC 组织中明显上调,功能实验表明 TP73-AS1 在 NSCLC 组织和细胞系中显著增加,表明其可能具有致癌作用。在功能丧失实验中,TP73-AS1 的敲低抑制了 NSCLC 细胞在体内和体外的增殖、肿瘤生长和周期进程。生物信息学工具预测 miR-449a 既靶向 TP73-AS1 的 3'-UTR,也靶向 EZH2,这通过荧光素酶报告基因检测和 AGO2 依赖性 RNA 免疫沉淀(RIP)得到了证实。TP73-AS1 和 miR-449a 位于相同的 RNA 诱导沉默复合物(RISC)中。总之,这些结果表明 TP73-AS1 在 NSCLC 肿瘤发生中具有明确的致癌作用,提示存在 TP73-AS1-miR-449a-EZH2 轴,并为 NSCLC 肿瘤发生提供了新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验